Skip to main content

MDMA · Pharmala Biotech Holdings Inc. · Insider Trading

0.15 CAD -0.015 (-9.09%) At close · Nov 6 Intraday price with Plus
Market Cap
16.53M CAD
Shares
110.18M
Volume · Nov 6 62.49K Avg daily vol (3M) 198.18K

Transactions in Pharmala Biotech Holdings Inc. securities by its insiders (directors, officers and significant shareholders) as filed on SEDI, the Canadian Securities Administrators' insider disclosure system.

Insider transactions

Insider transactions as filed on SEDI, each amended transaction at its newest amendment only. Capture began with about the year before its first read and grows daily, so older history is not included. Amounts are signed (negative for a disposition) and counted in the units of the security named, which may be options, share units or warrants rather than shares. Prices are in the stated currency. Holding after is the insider's balance of that security after the transaction, as filed.

Insider transactions filed on SEDI, the Canadian Securities Administrators' System for Electronic Disclosure by Insiders
Transaction dateInsiderTransactionSecurityAmountPriceHolding afterFiled
2026-07-27 Kadysh, Nicholas Director of Issuer Grant of rights Rights Performance Share UnitsUnderlying: Common Shares +1,000,000 1,000,000Direct 2026-07-29
2026-07-16 Macdonald, Fraser Director of Issuer Acquisition or disposition in the public market Common Shares -45,500 0.14 CAD 134,062Direct 2026-07-17
2026-07-14 Macdonald, Fraser Director of Issuer Acquisition or disposition in the public market Common Shares -16,000 0.135 CAD 179,562Direct 2026-07-14
2026-07-13 Macdonald, Fraser Director of Issuer Acquisition or disposition in the public market Common Shares -186,800 0.135 CAD 195,562Direct 2026-07-14
2026-07-13 Macdonald, Fraser Director of Issuer Acquisition or disposition in the public market Common Shares -300 0.14 CAD 382,362Direct 2026-07-14
2026-07-10 Macdonald, Fraser Director of Issuer Acquisition or disposition in the public market Common Shares -1,600 0.14 CAD 382,662Direct 2026-07-14
2026-07-10 Macdonald, Fraser Director of Issuer Acquisition or disposition in the public market Common Shares -21,738 0.135 CAD 384,262Direct 2026-07-14
2026-06-15 Macdonald, Fraser Director of Issuer Exercise of options Common Shares +100,000 0.1 CAD 406,000Direct 2026-06-17
2026-06-15 Macdonald, Fraser Director of Issuer Exercise of options OptionsUnderlying: Common Shares -100,000 350,000Direct 2026-06-17
2026-06-15 Heimpel Butts, Jodi Lynn Director of Issuer Exercise of options Common Shares +150,000 0.1 CAD 700,000Direct 2026-06-17
2026-06-15 Heimpel Butts, Jodi Lynn Director of Issuer Exercise of options OptionsUnderlying: Common Shares -150,000 450,000Direct 2026-06-17
2026-05-14 Tsergas, Perry Director of Issuer Exercise of options Common Shares +100,000 0.1 CAD 456,000Direct 2026-05-15
2026-05-14 Tsergas, Perry Director of Issuer Exercise of options OptionsUnderlying: Common Shares -100,000 0.1 CAD 350,000Direct 2026-05-15
2026-05-08 Ryer, Lennie Director of Issuer Acquisition or disposition in the public market Common Shares +36,000 0.15 CAD 36,000Direct 2026-05-21
2026-04-28 Kadysh, Nicholas Director of Issuer · Held by NKO Consulting Corp. Exercise of rights Common Shares +500,000 5,902,778Indirect 2026-04-30
2026-04-28 Kadysh, Nicholas Director of Issuer Exercise of rights Rights Restricted Share UnitsUnderlying: Common Shares -500,000 0Direct 2026-04-30
2026-04-28 Avery, William Edward Keith Senior Officer of Issuer · Held by Avery Professional Corporation Exercise of rights Common Shares +750,000 1,000,000Indirect 2026-04-30
2026-04-28 Avery, William Edward Keith Senior Officer of Issuer Exercise of rights Rights Restricted Share UnitsUnderlying: Common Shares -750,000 0Direct 2026-04-30
2026-04-28 Kazemzadeh, Farnoud Senior Officer of Issuer Acquisition or disposition in the public market Common Shares +267 1,553Direct 2026-04-30
2026-04-28 Kazemzadeh, Farnoud Senior Officer of Issuer Acquisition or disposition in the public market Common Shares +1,286 1,286Direct 2026-04-30
2026-04-20 Avery, William Edward Keith Senior Officer of Issuer · Held by Avery Professional Corporation Grant of optionsAmendment 1 OptionsUnderlying: Common Shares +1,000,000 1,100,000Indirect 2026-04-30
2026-04-20 Kadysh, Nicholas Director of Issuer Grant of options OptionsUnderlying: Common Shares +1,000,000 3,175,000Direct 2026-04-23
2026-04-20 Kazemzadeh, Farnoud Senior Officer of Issuer Grant of options OptionsUnderlying: Common Shares +1,000,000 2,000,000Direct 2026-04-23
2026-04-20 Ryer, Lennie Director of Issuer Grant of options OptionsUnderlying: Common Shares +250,000 250,000Direct 2026-04-23
2026-04-20 Tsergas, Perry Director of Issuer Grant of options OptionsUnderlying: Common Shares +250,000 450,000Direct 2026-04-23
2026-04-20 Macdonald, Fraser Director of Issuer Grant of options OptionsUnderlying: Common Shares +250,000 450,000Direct 2026-04-23
2026-04-20 Roy, Kevin Joseph Sylvio Director of Issuer Grant of options OptionsUnderlying: Common Shares +250,000 650,000Direct 2026-04-23
2026-04-20 Heimpel Butts, Jodi Lynn Director of Issuer Grant of options OptionsUnderlying: Common Shares +350,000 600,000Direct 2026-04-23
2026-02-09 Ryer, Lennie Director of Issuer Opening Balance-Initial SEDI Report Common Shares 0 Direct 2026-05-21
2026-02-09 Ryer, Lennie Director of Issuer Opening Balance-Initial SEDI Report OptionsUnderlying: Common Shares 0 Direct 2026-04-23

30 transactions between 2026-02-09 and 2026-07-27. Checked 2026-11-08 16:58 UTC.

Showing 1–30 of 30 transactions